Is a rare CXCL8 gene variant a new possible cause or course factor of inflammatory bowel disease?
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | 0000-0002-1496-1502 | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.author-orcid | f22f1799-d4c9-4523-90d4-f2f2bc6eab63 | |
cris.virtualsource.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.author-orcid | a706896c-13b8-4acd-8e84-35ef99d53321 | |
cris.virtualsource.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
dc.abstract.en | Introduction: The pathogenesis of inflammatory bowel diseases (IBD) involves genetic, environmental, immunological, and microbial factors; however, it remains unclear. Pro-inflammatory interleukin 8 (IL-8), encoded by the CXCL8 gene, assumes a crucial chemotactic role in leukocyte migration. Methods: This study aimed to investigate whether an association exists between IBD and two CXCL8 variants, namely, c.-251A>T (rs4073) and c.91G>T (rs188378669), and IL-8 concentration. We analyzed the distribution of both variants among 353 Polish IBD patients and 200 population subjects using pyrosequencing, competitive allele-specific PCR and Sanger sequencing. Results: The c.91T stop-gained allele was significantly more frequent in IBD patients (2.12%) than in controls (0.25%) (p = 0.0121), while the c.-251T allele frequencies were similar (54% vs. 51.5%, p = 0.4955). Serum IL-8 concentrations, measured using ELISA, were higher in IBD patients with the c.91 GG genotype compared to healthy controls (mean, 70.02 vs. 51.5 pg/ml, p<0.01) and patients with c.91 GT (mean, 61.73 pg/ml). Moreover, clinical data indicated that carriers of the c.91T variant need more often corticosteroids and surgical treatment of the disease than GG homozygous IBD patients. Conclusion: This suggest that the CXCL8 c.91T allele may influence IBD manifestation and the course of the disorders in Polish patients, potentially serving as a novel target for future studies and therapeutic approaches | |
dc.affiliation | Wydział Rolnictwa, Ogrodnictwa i Biotechnologii | |
dc.affiliation.institute | Katedra Biochemii i Biotechnologii | |
dc.contributor.author | Gabryel, Marcin | |
dc.contributor.author | Zakerska-Banaszak, Oliwia | |
dc.contributor.author | Ladziak, Karolina | |
dc.contributor.author | Hubert, Katarzyna Anna | |
dc.contributor.author | Baturo, Alina | |
dc.contributor.author | Suszyńska-Zajczyk, Joanna | |
dc.contributor.author | Hryhorowicz, Magdalena Julita | |
dc.contributor.author | Dobrowolska, Agnieszka | |
dc.contributor.author | Skrzypczak-Zielinska, Marzena | |
dc.date.access | 2025-06-11 | |
dc.date.accessioned | 2025-06-11T10:14:54Z | |
dc.date.available | 2025-06-11T10:14:54Z | |
dc.date.copyright | 2025-03-19 | |
dc.date.issued | 2025 | |
dc.description.abstract | <jats:sec><jats:title>Introduction</jats:title><jats:p>The pathogenesis of inflammatory bowel diseases (IBD) involves genetic, environmental, immunological, and microbial factors; however, it remains unclear. Pro-inflammatory interleukin 8 (IL-8), encoded by the <jats:italic>CXCL8</jats:italic> gene, assumes a crucial chemotactic role in leukocyte migration.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>This study aimed to investigate whether an association exists between IBD and two <jats:italic>CXCL8</jats:italic> variants, namely, c.-251A&gt;T (rs4073) and c.91G&gt;T (rs188378669), and IL-8 concentration. We analyzed the distribution of both variants among 353 Polish IBD patients and 200 population subjects using pyrosequencing, competitive allele-specific PCR and Sanger sequencing.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The c.91T stop-gained allele was significantly more frequent in IBD patients (2.12%) than in controls (0.25%) (<jats:italic>p</jats:italic> = 0.0121), while the c.-251T allele frequencies were similar (54% vs. 51.5%, <jats:italic>p</jats:italic> = 0.4955). Serum IL-8 concentrations, measured using ELISA, were higher in IBD patients with the c.91 GG genotype compared to healthy controls (mean, 70.02 vs. 51.5 pg/ml, <jats:italic>p</jats:italic>&lt;0.01) and patients with c.91 GT (mean, 61.73 pg/ml). Moreover, clinical data indicated that carriers of the c.91T variant need more often corticosteroids and surgical treatment of the disease than GG homozygous IBD patients.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>This suggest that the <jats:italic>CXCL8</jats:italic> c.91T allele may influence IBD manifestation and the course of the disorders in Polish patients, potentially serving as a novel target for future studies and therapeutic approaches.</jats:p></jats:sec> | |
dc.description.accesstime | at_publication | |
dc.description.bibliography | il., bibliogr. | |
dc.description.finance | other | |
dc.description.financecost | 2500,00 | |
dc.description.if | 5,7 | |
dc.description.points | 140 | |
dc.description.version | final_published | |
dc.description.volume | 16 | |
dc.identifier.doi | 10.3389/fimmu.2025.1562618 | |
dc.identifier.issn | 1664-3224 | |
dc.identifier.uri | https://sciencerep.up.poznan.pl/handle/item/2828 | |
dc.identifier.weblink | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1562618/full | |
dc.language | en | |
dc.relation.ispartof | Frontiers in Immunology | |
dc.relation.pages | art. 1562618 | |
dc.rights | CC-BY | |
dc.sciencecloud | nosend | |
dc.share.type | OPEN_JOURNAL | |
dc.subject.en | CXCL8 gene | |
dc.subject.en | inflammatory bowel disease (IBD) | |
dc.subject.en | inflammation | |
dc.subject.en | interleukin 8 | |
dc.subject.en | genetic variants | |
dc.subject.en | Crohns disease | |
dc.subject.en | colitis ulcerosa | |
dc.title | Is a rare CXCL8 gene variant a new possible cause or course factor of inflammatory bowel disease? | |
dc.type | JournalArticle | |
dspace.entity.type | Publication | |
oaire.citation.volume | 16 |